Use of Progesterone for Prevention of SPB

Use of Progesterone for Prevention of SPB
Preterm birth (delivery before 37 weeks gestation) affects 15 million pregnancies worldwide and significantly increases the risk for neonatal complications. Spontaneous preterm birth contributes largely to the prevalence of preterm birth. The 2020 SOGC Clinical practice guideline, "Use of Progesterone for Prevention of Spontaneous Preterm Birth", shares recent evidence on vaginal progesterone therapy to prevent the risk of spontaneous preterm birth. The guideline presents risk factors and prescription information, including recommended dose and duration. Additionally, the guideline discusses safety of use and alternate therapies. After reviewing the guideline, members may complete the Guideline Resource Kit including an online quiz that will contribute towards continuing medical education credits, and download resources including a prescription reminder sheet.


This event is an Accredited Self-Assessment Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal college of Physicians and Surgeons of Canada, and approved by the Society of Obstetricians and Gynaecologists of Canada. You may claim a maximum of 1.0 hour.

Once you have registered, you can access the course by going to your profile and clicking on "Go to SOGC Online Platform".

This activity is for SOGC members only.

2/6/2020 8:00 AM - 12/31/2025 11:59 PM
Eastern Standard Time
Registration not available.

Sign In